⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

ATAI

AtaiBeckley Inc.

Healthcare · Biotechnology

7.29USD

+0.0100 (+0.14%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)2024202520262027
FY308.0K4.1M2.3M545.5K
Q1—1.6M954.0K—
Q2—719.0K1.7M—
Q3——200.0K—
Q4——200.0K—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)2024202520262027
FY-.930-2.91-.432-.490
Q1—-.150-.080—
Q2—-.140-.090—
Q3——-.123—
Q4——-.132—

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.